Glaukos Stock

Glaukos FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Glaukos (GKOS) as of Aug 17, 2026 is 28.77 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 46.20 % — a change of -37.71% (lower).

FCF Conversion

28.77 %

YoY

-37.71%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Glaukos is 2026 28.77 % . FCF Conversion Rate (FCF/EBITDA) of Glaukos was 2025 46.20 % . It decreases by -37.71% lower compared to the previous year.
Access this data via the Eulerpool API

Glaukos Stock analysis

What does Glaukos do? Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Glaukos stock

FCF Conversion Rate (FCF/EBITDA) of Glaukos is 28.77 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Glaukos changed from 46.20 % to 28.77 %, representing a -37.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Glaukos since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Glaukos with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Glaukos

All Key Metrics — Glaukos